Albert Capellani directeur artistique de la SCAGL ou l’émergence de l’auteur

Les débuts Avant d’être nommé directeur artistique de la Société Cinématographique des Auteurs et Gens de Lettres, dès sa création en 1908, Albert Capellani débute sa carrière comme acteur au Théâtre Libre d’André Antoine puis devient régisseur du théâtre de Firmin Gémier. En 1904, il est administrateur de la scène de l’Alhambra où il dirige bon nombre de ballets. Il quitte ensuite le milieu théâtral en 1905, quand le directeur de la production de Pathé, Ferdinand Zecca, lui propose de l’enga..

Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent injection

ObjectiveTo investigate the pharmacodynamic disposition of two recently developed β-lactam antibiotics, meropenem and cefpirome, in the Yucatan micropig model, and to compare the bactericidal activity of these drugs against bacteria in this in vitro/ex vivo micropig model after administration by both intermittent injection and continuous infusion.MethodsCefpirome (1 g) was given to the micropig over a 12-h period by direct intravenous injection and 6-h continuous infusion (500 mg). Meropenem (250 mg) was administered either by 30-min intravenous and 8-h continuous infusion. The two drugs were assayed by HPLC. The pharmacodynamics of these drugs were evaluated by means of (1) serum killing curve against Klebsiella pneumoniae producing extended-spectrum β-lactamase, stably derepressed Enterobacter cloacae and methicillin-susceptible penicillinase-producing Staphylococcus aureus, and (2) calculations of index of surviving bacteria (ISB).ResultsThe bactericidal activity of meropenem against K. pneumoniae and E. cloacae in this in vitro/ex vivo model was excellent, with a 4 log decrease at peak concentrations. Meropenem produced a mixed concentration- and time-dependent, killing effect against E. cloacae and K. pneumoniae. The ISB value ranged from 25% to 30% for E. cloacae. With concentrations above MIC for S. aureus (1 mg/L), cefpirome has a time-dependent bactericidal activity, as shown by the ISB ranging from 20% to 80% after 4 h and between 20% and 40% after an 8-h drug exposure. For both antibiotics, the higher concentrations obtained just after intermittent injection had a rapid and strong killing effect against the strains tested, but the trough levels had no bactericidal activity. The continuous infusions produce consistent concentrations of antibiotic that can be maintained above the MIC, and the bactericidal activity of which ranges from 2 to 4 log10 decrease of inoculum.ConclusionsIn the present study the micropig has been shown to be an adequate model for the pharmacodynamic investigation of cefpirome and meropenem. In general, continuous infusion appears to optimize the pharmacodynamic profile of the two tested β-lactam antibiotics. However, against Gram-negative bacilli, the administration of a loading dose prior to continuous infusion of β-lactams would eliminate the only potential pharmacokinetic disadvantage of continuous infusion and ensure the rapid onset of antimicrobial activity

Low genetic diversity contrasts with high phenotypic variability in heptaploid Spartina densiflora populations invading the Pacific coast of North America

Species can respond to environmental pressures through genetic and epigenetic changes and through phenotypic plasticity, but few studies have evaluated the relationships between genetic differentiation and phenotypic plasticity of plant species along changing environmental conditions throughout wide latitudinal ranges. We studied inter‐ and intrapopulation genetic diversity (using simple sequence repeats and chloroplast DNA sequencing) and inter‐ and intrapopulation phenotypic variability of 33 plant traits (using field and common‐garden measurements) for five populations of the invasive cordgrass Spartina densiflora Brongn. along the Pacific coast of North America from San Francisco Bay to Vancouver Island. Studied populations showed very low genetic diversity, high levels of phenotypic variability when growing in contrasted environments and high intrapopulation phenotypic variability for many plant traits. This intrapopulation phenotypic variability was especially high, irrespective of environmental conditions, for those traits showing also high phenotypic plasticity. Within‐population variation represented 84% of the total genetic variation coinciding with certain individual plants keeping consistent responses for three plant traits (chlorophyll b and carotenoid contents, and dead shoot biomass) in the field and in common‐garden conditions. These populations have most likely undergone genetic bottleneck since their introduction from South America; multiple introductions are unknown but possible as the population from Vancouver Island was the most recent and one of the most genetically diverse. S. densiflora appears as a species that would not be very affected itself by climate change and sea‐level rise as it can disperse, establish, and acclimate to contrasted environments along wide latitudinal ranges

OPTIMISATION DE L’HYDRODYNAMIQUE D’UN PHOTOBIOREACTEUR TUBULAIRE DE TYPE AIRLIFT FAVORISANT LA FORMATION DE BIOFLOCS

L'augmentation de la population mondiale et de l'urbanisation qui sont à l'origine du changement climatique ont poussé les gouvernements à imposer des politiques pour réduire les émissions des gaz à effet de serre (GES). Par ailleurs les procédés de traitement biologique des eaux usées sont pénalisés énergétiquement et ils ne sont pas durables par leur consommation d’oxygène, les nuisances causées par les boues et les odeurs et par l’émission des gaz à effet de serre particulièrement le CO2. L'utilisation des microalgues pour traiter les eaux usées fait l'objet d'une attention croissante dans le monde car elle est considérée comme un nouveau moyen de traitement des eaux usées. En particulier, l'intégration de microalgues dans le cadre de procédés d’épuration multitrophiques permet d’envisager des solutions de traitement des eaux sans apport d'O2 et sans rejet de CO2. Il est communément admis que la culture à grande échelle et l'application commerciale des microalgues sont limitées par le développement du photobioréacteur (PBR). Bien qu'il existe des nombreux types de PBR pour la culture pure de microalgues dans des milieux de culture définis, un nouveau design de PBR doit être envisagé dans le cas de cultures multitrophiques utilisées pour l’épuration des eaux. Un PBR tubulaire avec airlift a donc été conçu. Un pilote a été construit pour étudier les aspects hydrodynamiques et le transfert de matière, dans le but d’optimiser le traitement des eaux usées Afin de minimiser la formation de biofilm sur la paroi et limiter la diffusion de la lumière, un écoulement avec des flocs des microalgues est généré. Le PBR d’étude conçue a servi de base aux études de transferts hydrodynamiques et biologiques. Les études hydrodynamiques (traçage conductimétrique) ont donné accès aux vitesses d’écoulement, le temps de circulation et le temps de mélange. Différents débits de gaz et différents types et positions de l’injecteurs de gaz ont été testés. En complément, les performances de transfert de matière gaz-liquide du réacteur ont été déterminées, afin de confirmer la possibilité de transférer efficacement l’oxygène produit photosynthétiquement Sur base des informations expérimentales collectées, le design de PBR et les conditions opératoires optimales pour une culture active de microalgues ont été optimisés. Les facteurs pris en compte sont le temps de séjour hydraulique, le transfert de matière gaz-liquide et le temps de mélange. L’objectif est d’assurer une distribution adéquate (uniforme et dans la gamme optimale) des concentrations en nutriments, en gaz O2 et CO2, ainsi que de la lumière, dans l’ensemble du réacteur.TRAITEMENT DES EAUX USEES SANS APPORT D’O2 ET SANS DEGAGEMENT DE CO2 ET DEVELOPPEMENT D’UN PHOTOBIOREACTEUR INNOVANT3. Good health and well-bein

Is the breast-conserving treatment with radiotherapy appropriate in mutation carriers? Long-term results and review of the literature

International audienceAs tumours in mutation carriers might be more sensitive to radiation, we investigated after long-term follow-up whether mutation status influenced the rate of ipsilateral and contralateral breast cancers after breast-conserving treatment (BCT). and genes were screened for germline mutations in 131 patients with a family history of breast and/or ovarian cancer who had undergone BCT and radiotherapy. Patients were matched to 261 controls with sporadic breast cancer according to age at diagnosis and year of treatment. Controls were followed up for at least as long as the interval between diagnosis and genetic screening in familial cases. Rates of ipsilateral and contralateral cancer between groups were compared by the log-rank test. The mutations occurred in 20.6% of tested patients. Tumours in mutation carriers were more likely to be grade III ( < 10) and oestrogen receptor negative ( = 0.005) than in non-carriers and controls. Overall median follow-up was 161 months. There was no significant difference in ipsilateral tumours between mutation carriers, non-carriers and controls ( = 0.13). On multivariate analysis, age was the most significant predictor for ipsilateral recurrence ( < 10). The rate of contralateral cancer was significantly higher in familial cases: 40.7% (mutation carriers), 20% (non-carriers), and 11% (controls) ( < 10). After 13.4 years of follow-up, the rate of ipsilateral tumours was no higher in mutation carriers than in non-carriers or controls. As tumours in mutation carriers might be more sensitive to radiation, BCT is a possible treatment option

Convective Drying of Mixtures of Sewage Sludge and Sawdust in a Fixed Bed

This work is part of a project aiming at developing a renewable fuel for gasification purposes, through the convective drying of sludge/wood mixtures. The first step consists in characterizing the drying behaviour of sludge/sawdust mixtures, in a convective fixed bed dryer. In particular, the influence of the mixing step (no mixing against 30 s at 40 rpm) and the sawdust/sludge ratio (1/9, 2/8, 3/7 and 4/6 on a dry basis) have been investigated, as well as the drying temperature (50 °C, 80 °C and 110 °C). As showed in a previous work, the addition of dry matter into sludge has an impact on the initial 3D structure of the bed of extrudates to be dried. Moreover, it is well known that the volume shrinkage occurring during sludge drying will affect the drying velocity. In this study, X-ray tomography, a non-invasive imaging technique, is used to assess changes in volume, porosity and exchange surface between the beginning and the end of the drying process. Results first confirm the importance of the mixing step on the drying behaviour: the drying rate of the mixed sludge is slower than the one of original sludge. Nevertheless the addition of sawdust is shown to have a positive impact on the drying process from mass ratio of 2/8, with observed drying rates higher than for the original sludge. During the whole drying process, the volume and exchange surface of the sample increase and the porosity decreases as the mass ratio increases. These results indicate that the air and the sample contact more fully with more sawdust addition, resulting from bed expansion and exchange surface increase. Hence, the heat and mass transfer efficiency between the air and the material increases and consequently the drying rate. Further work will be done in order to assess the impact of the drying temperature and to characterize the behaviour of these samples during pyrolysis using thermo gravimetric analysis

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)

<p>Abstract</p> <p>Background</p> <p>Treatment for the hepatitis C virus (HCV) may be delayed significantly in HIV/HCV co-infected patients. Our study aims at identifying the correlates of access to HCV treatment in this population.</p> <p>Methods</p> <p>We used 3-year follow-up data from the HEPAVIH ANRS-CO13 nationwide French cohort which enrolled patients living with HIV and HCV. We included pegylated interferon and ribavirin-naive patients (N = 600) at enrolment. Clinical/biological data were retrieved from medical records. Self-administered questionnaires were used for both physicians and their patients to collect data about experience and behaviors, respectively.</p> <p>Results</p> <p>Median [IQR] follow-up was 12[12-24] months and 124 patients (20.7%) had started HCV treatment. After multiple adjustment including patients' negative beliefs about HCV treatment, those followed up by a general practitioner working in a hospital setting were more likely to receive HCV treatment (OR[95%CI]: 1.71 [1.06-2.75]). Patients followed by general practitioners also reported significantly higher levels of alcohol use, severe depressive symptoms and poor social conditions than those followed up by other physicians.</p> <p>Conclusions</p> <p>Hospital-general practitioner networks can play a crucial role in engaging patients who are the most vulnerable and in reducing existing inequities in access to HCV care. Further operational research is needed to assess to what extent these models can be implemented in other settings and for patients who bear the burden of multiple co-morbidities.</p

Новое в развитии пластической хирургии носа

Рассмотрены проблемы, возникающие при реконструктивных вмешательствах на структурах наружного носа и его внутренних полостях, характеристики трансплантатов и условия, способствующие возникновению осложнений. На основании собственных наблюдений сделан вывод о практической целесообразности использования гомо− и гетеротрансплантатов с учетом конкретных медико−социальных показаний.The problems arising at reconstructive surgery on the external structures of the nose and its inner cavities as well as characteristics of the implants and the conditions promoting complication development are featured. Basing on the original research the authors conclude about practical expediency of application of homo− and heterotransplants with the account of definite medical−social parameters

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

Reactivation of latent Mycobacterium tuberculosis (Mtb) infection is a major complication of anti-tumour necrosis factor (TNF)-α treatment, but its mechanism is not fully understood. We evaluated the effect of the TNF antagonists infliximab (Ifx), adalimumab (Ada) and etanercept (Eta) on anti-mycobacterial immune responses in two conditions: with ex vivo studies from patients treated with TNF antagonists and with the in vitro addition of TNF antagonists to cells stimulated with mycobacterial antigens. In both cases, we analysed the response of CD4(+ )T lymphocytes to purified protein derivative (PPD) and to culture filtrate protein (CFP)-10, an antigen restricted to Mtb. The tests performed were lymphoproliferation and immediate production of interferon (IFN)-γ. In the 68 patients with inflammatory diseases (rheumatoid arthritis, spondylarthropathy or Crohn's disease), including 31 patients with a previous or latent tuberculosis (TB), 14 weeks of anti-TNF-α treatment had no effect on the proliferation of CD4(+ )T lymphocytes. In contrast, the number of IFN-γ-releasing CD4(+ )T lymphocytes decreased for PPD (p < 0.005) and CFP-10 (p < 0.01) in patients with previous TB and for PPD (p < 0.05) in other patients (all vaccinated with Bacille Calmette-Guérin). Treatments with Ifx and with Eta affected IFN-γ release to a similar extent. In vitro addition of TNF antagonists to CD4(+ )T lymphocytes stimulated with mycobacterial antigens inhibited their proliferation and their expression of membrane-bound TNF (mTNF). These effects occurred late in cultures, suggesting a direct effect of TNF antagonists on activated mTNF(+ )CD4(+ )T lymphocytes, and Ifx and Ada were more efficient than Eta. Therefore, TNF antagonists have a dual action on anti-mycobacterial CD4(+ )T lymphocytes. Administered in vivo, they decrease the frequency of the subpopulation of memory CD4(+ )T lymphocytes rapidly releasing IFN-γ upon challenge with mycobacterial antigens. Added in vitro, they inhibit the activation of CD4(+ )T lymphocytes by mycobacterial antigens. Such a dual effect may explain the increased incidence of TB in patients treated with TNF antagonists as well as possible differences between TNF antagonists for the incidence and the clinical presentation of TB reactivation

Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial

The objective was to compare the safety and cellular immunogenicity of intradermal versus intramuscular immunization with an HIV-lipopeptide candidate vaccine (LIPO-4) in healthy volunteers.A randomized, open-label trial with 24 weeks of follow-up was conducted in France at six HIV-vaccine trial sites. Sixty-eight healthy 21- to 55-year-old HIV-uninfected subjects were randomized to receive the LIPO-4 vaccine (four HIV lipopeptides linked to a T-helper-stimulating epitope of tetanus-toxin protein) at weeks 0, 4 and 12, either intradermally (0.1 ml, 100 microg of each peptide) or intramuscularly (0.5 ml, 500 microg of each peptide). Comparative safety of both routes was evaluated. CD8+ T-cell immune responses to HIV epitopes (ELISpot interferon-gamma assay) and tetanus toxin-specific CD4+ T-cell responses (lymphoproliferation) were assessed at baseline, two weeks after each injection, and at week 24.No severe, serious or life-threatening adverse events were observed. Local pain was significantly more frequent after intramuscular injection, but local inflammatory reactions were more frequent after intradermal immunization. At weeks 2, 6, 14 and 24, the respective cumulative percentages of induced CD8+ T-cell responses to at least one HIV peptide were 9, 33, 39 and 52 (intradermal group) or 14, 20, 26 and 37 (intramuscular group), and induced tetanus toxin-specific CD4+ T-cell responses were 6, 27, 33 and 39 (intradermal), or 9, 46, 54 and 63 (intramuscular). In conclusion, intradermal LIPO-4 immunization was well tolerated, required one-fifth of the intramuscular dose, and induced similar HIV-specific CD8+ T-cell responses. Moreover, the immunization route influenced which antigen-specific T-cells (CD4+ or CD8+) were induced.ClinicalTrials.gov NCT00121121